4 results
8-K
EX-99.1
LEXX
Lexaria Bioscience Corp
6 Nov 20
Lexaria Bioscience Advances 2021 Strategic Initiatives
12:00am
treatment of several medical conditions including opioid and other substance abuse, anxiety and more. In harmony with the increased scientific
8-K
LEXX
Lexaria Bioscience Corp
30 Aug 19
Regulation FD Disclosure
12:00am
), marijuana abuse, and alcohol, opioid, nicotine or cocaine addiction.
In addition, the claims granted in these two new patent families specify a wide range
8-K
EX-99.2
LEXX
Lexaria Bioscience Corp
2 Aug 18
Lexaria Bioscience and Hill Street Beverage Company Announce Definitive Agreement for Cannabis-Infused Beverages
5:16pm
Sinai results, although potentially influenced by concomitant opioid administration within that study, were substantially lower than the 56.0 ng/mL peak
- Prev
- 1
- Next